Filtros de búsqueda

Lista de obras de William Jeffery Sandborn

52-week efficacy of adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressants

artículo científico publicado en 2013

A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn’s Disease.

artículo científico publicado en 2018

A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis

scientific article published on 04 August 2020

A Systematic Review for the Development of a Core Outcome Set for Ulcerative Colitis Clinical Trials

artículo científico publicado en 2017

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

scientific article published on 22 December 2019

A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score

article

A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine

artículo científico publicado en 2005

A gp130-Src-YAP module links inflammation to epithelial regeneration

artículo científico publicado en 2015

A moveable feast

scientific article published on 01 June 2007

A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease

artículo científico publicado en 2014

A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis

artículo científico publicado en 2007

A phase II study of laquinimod in Crohn's disease

artículo científico publicado en 2014

A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease

artículo científico publicado en 2012

A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis

artículo científico publicado en 2014

A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohnʼs disease and ulcerative colitis

article

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease

artículo científico

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

article

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis

artículo científico publicado en 2008

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

artículo científico publicado en 2014

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

artículo científico publicado en 2006

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

artículo científico publicado en 2002

A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

artículo científico publicado en 2007

A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn's disease: recommendations for clinical trial design

artículo científico publicado en 2014

A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research

artículo científico publicado en 2014

A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab

artículo científico publicado en 2013

AGA Institute Future Trends Committee report: the future of gastroenterology training programs in the United States.

artículo científico publicado en 2008

AGA technical review on perianal Crohn’s disease ⬇️

artículo científico publicado el 1 de noviembre de 2003

Abatacept for Crohn's disease and ulcerative colitis

artículo científico publicado en 2012

Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn's Disease

artículo científico publicado en 2017

Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography

artículo científico publicado en 2006

Acute pancreatitis in patients with Crohn's disease: clinical features and outcomes

artículo científico publicado en 2005

Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patients

artículo científico publicado en 2010

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

artículo científico publicado en 2011

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

artículo científico publicado en 2006

Adalimumab for the treatment of fistulas in patients with Crohn's disease

artículo científico publicado en 2009

Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis

artículo científico publicado en 2011

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial

artículo científico publicado en 2012

Adalimumab induces deep remission in patients with Crohn's disease.

artículo científico publicado en 2013

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

artículo científico publicado en 2007

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE.

artículo científico publicado en 2013

Adalimumab safety in global clinical trials of patients with Crohn's disease

artículo científico publicado en 2009

Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease

artículo científico publicado en 2010

Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease

artículo científico publicado en 2011

Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis

artículo científico publicado en 2013

Advances in the treatment of Crohn's disease

artículo científico publicado en 2004

Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trial

artículo científico publicado en 2015

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.

artículo científico publicado en 2007

An evidence-based systematic review on medical therapies for inflammatory bowel disease

artículo científico publicado en 2011

An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease

artículo científico publicado en 2018

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials

artículo científico publicado en 2021

An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease

artículo científico publicado en 2004

An overview of magnetic resonance enterography for Crohn's disease

artículo científico

An update on the epidemiology of inflammatory bowel disease in Asia

artículo científico publicado en 2008

Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease.

artículo científico publicado en 2018

Andrographis paniculata extract (HMPL-004) for active ulcerative colitis

artículo científico publicado en 2012

Annual Burden and Costs of Hospitalization for High-Need, High-Cost Patients with Chronic Gastrointestinal and Liver Diseases

artículo científico publicado en 2018

Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis

artículo científico publicado en 2010

Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study

scientific article published on 05 March 2013

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.

artículo científico publicado en 2017

Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms

artículo científico

Anti-interleukin-12 antibody for active Crohn's disease

artículo científico publicado en 2004

Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients

artículo científico publicado en 2012

Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressives

artículo científico publicado en 2016

Application of Artificial Intelligence to Gastroenterology and Hepatology

artículo científico publicado en 2019

Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases

scientific article published on 19 June 2019

Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results

artículo científico publicado en 2016

Assessment of appropriateness of indications for CT enterography in younger patients

artículo científico publicado en 2010

Assessment of histologic disease activity in Crohn's disease: a systematic review

artículo científico publicado en 2014

Assessment of mucosal healing in inflammatory bowel disease: review.

artículo científico

Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy--feasibility study

artículo científico publicado en 2003

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis

artículo científico publicado en 2015

Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease.

artículo científico publicado en 2013

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis

artículo científico publicado en 2014

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study

artículo científico publicado en 2020

Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's disease

artículo científico publicado en 2013

Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study

artículo científico publicado en 2004

Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications

artículo científico publicado en 2002

Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration

artículo científico publicado en 1996

Azathioprine-induced neuro-psychiatric disorders

artículo científico publicado en 2013

Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease

artículo científico publicado en 2004

Baseline Clearance of Infliximab is Associated with Requirement for Colectomy in Patients with Acute Severe Ulcerative Colitis

scientific article published on 26 April 2020

Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies

artículo científico publicado en 2016

Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis

artículo científico publicado en 2012

Benefit of computed tomography enterography in Crohn's disease: effects on patient management and physician level of confidence

artículo científico publicado en 2011

Best of DDW 2006

scientific article published on 01 January 2006

Biologic concentration testing in inflammatory bowel disease

artículo científico publicado en 2015

Biologic therapy of inflammatory bowel disease.

artículo científico publicado en 2002

Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity

artículo científico publicado en 2018

Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis

article

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease

scientific article published on 12 November 2020

Biomarkers for assessing disease activity in inflammatory bowel disease

artículo científico publicado en 2013

Biosimilars in IBD: hope or expectation?

artículo científico

Briakinumab for treatment of Crohn's disease: results of a randomized trial

artículo científico publicado en 2015

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis

artículo científico publicado en 2015

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis

artículo científico publicado en 2015

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

artículo científico publicado en 2017

Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis

artículo científico publicado en 2015

Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials

artículo científico publicado en 2005

Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practice

artículo científico publicado en 2006

C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

artículo científico

CLASSIC-I study the efficacy of adalimumab

scientific article published on 01 May 2006

Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts

scientific article published on 01 January 2019

Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials

artículo científico

Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study

artículo científico publicado en 2017

Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trial

artículo científico publicado en 2011

Certolizumab pegol for the treatment of Crohn's disease

artículo científico publicado en 2007

Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab

artículo científico publicado en 2010

Challenges in IBD Research: updating the scientific agendas

artículo científico publicado en 2003

Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda

scientific article published on March 2013

Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease

artículo científico

Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC.

artículo científico publicado en 2015

Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes

scientific article published on 01 October 2019

Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life

artículo científico

Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn's Disease: Results from the EXTEND Trial

artículo científico publicado en 2016

Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study

artículo científico publicado en 2013

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study

artículo científico publicado en 2009

Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials.

artículo científico publicado en 2018

Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease

artículo científico publicado en 2018

Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 study

artículo científico publicado en 2015

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

artículo científico publicado en 2013

Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study

artículo científico publicado en 2009

Clinical management of pouchitis

artículo científico publicado en 2004

Clinical scenarios in IBD: Optimizing the use of conventional and biologic agents ⬇️

artículo científico publicado el 1 de diciembre de 2010

Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials

artículo científico publicado en 2009

Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease

artículo científico publicado en 2010

Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial

artículo científico publicado en 2020

Colectomy and the incidence of postsurgical complications among ulcerative colitis patients with private health insurance in the United States.

artículo científico publicado en 2008

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

artículo científico publicado en 2009

Colectomy subtypes, follow-up surgical procedures, postsurgical complications, and medical charges among ulcerative colitis patients with private health insurance in the United States

artículo científico publicado en 2009

Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management

artículo científico publicado en 2016

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis

artículo científico publicado en 2018

Comment on 'anti-adhesion therapies and the rule of 3 for rare events'.

artículo científico publicado en 2014

Comparative Efficacy and Speed of Onset of Action of Infliximab vs Golimumab in Ulcerative Colitis

artículo científico publicado en 2019

Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

artículo científico publicado en 2020

Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis

artículo científico publicado en 2019

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

artículo científico publicado en 2020

Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses

scientific article published on 17 August 2018

Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease

scientific article published on 13 July 2020

Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases

artículo científico publicado en 2018

Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States

artículo científico publicado en 2016

Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial

artículo científico publicado en 2009

Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease

artículo científico publicado en 2011

Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease

artículo científico publicado en 2018

Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease

artículo científico publicado en 2017

Contemporary Risk of Surgery in Patients with Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-based Cohorts

artículo científico publicado en 2020

Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab

artículo científico publicado en 2019

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

artículo científico publicado en 2010

Converging goals of treatment of inflammatory bowel disease from clinical trials and practice

artículo científico publicado en 2014

Correction: No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials

artículo científico publicado en 2019

Correction: Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials

artículo científico publicado en 2019

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

article

Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial

artículo científico publicado en 2015

Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity

artículo científico publicado en 2010

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

artículo científico publicado en 2005

Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease

artículo científico publicado en 2020

Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

artículo científico publicado en 2017

Corrigendum: Evolving Concepts in Phases I and II Drug Development for Crohn's Disease

artículo científico publicado en 2018

Corrigendum: Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

artículo científico publicado en 2018

Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease

artículo científico publicado en 2017

Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease

scientific article published on 01 March 2020

Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease

artículo científico publicado en 2011

Crohn Disease: mural attenuation and thickness at contrast-enhanced CT Enterography--correlation with endoscopic and histologic findings of inflammation

artículo científico publicado en 2006

Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab

artículo científico publicado en 2016

Crohn's disease

artículo científico publicado en 2012

Crohn's disease complicated by strictures: a systematic review

artículo científico publicado en 2013

Crohn's disease: beyond antagonists of tumour necrosis factor

artículo científico publicado en 2008

Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis

artículo científico publicado en 2016

Cumulative Length of Bowel Resection in a Population-Based Cohort of Patients With Crohn's Disease

artículo científico publicado en 2016

Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis

artículo científico publicado en 2013

Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?

artículo científico publicado en 2020

Cyclosporin for refractory ulcerative colitis

artículo científico publicado en 2003

Cyclosporine treatment of inflammatory bowel disease

artículo científico publicado el 1 de octubre de 1992

Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease

artículo científico publicado en 2004

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

artículo científico publicado en 2006

Deep remission with vedolizumab in patients with moderately to severely active ulcerative colitis: a GEMINI 1 post hoc analysis

artículo científico publicado en 2019

Deep remission: a new concept?

artículo científico

Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions

artículo científico publicado en 2016

Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design

scientific article published on 19 September 2020

Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease

artículo científico publicado en 2008

Definitions of response and remission for the Robarts Histopathology Index

artículo científico publicado en 2018

Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusion

artículo científico publicado en 2002

Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis

artículo científico publicado en 2009

Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial

artículo científico publicado en 2005

Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease

artículo científico publicado en 2004

Design issues and outcomes in IBD clinical trials

artículo científico publicado en 2005

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

artículo científico publicado en 2011

Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

scientific article published on 13 February 2020

Development and Validation of a Clinical Decision Support Tool That Incorporates Pharmacokinetic Data to Predict Endoscopic Healing in Patients Treated With infliximab

scientific article published on 03 May 2020

Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease

scientific article published on 20 July 2019

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease

scientific article published on 30 May 2018

Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins

scientific article published on 08 November 2019

Development and validation of a histological index for UC.

artículo científico publicado en 2015

Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.

artículo científico publicado en 2017

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative

artículo científico

Development of a Microscopic Colitis Disease Activity Index: a prospective cohort study

artículo científico publicado en 2016

Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

artículo científico

Development of an index to define overall disease severity in IBD.

artículo científico publicado en 2016

Development of gut-selective pan-Janus kinase inhibitor TD-1473 for ulcerative colitis: A translational medicine program

scientific article published on 11 March 2020

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

artículo científico publicado en 2015

Development of the Crohn's disease digestive damage score, the Lémann score

artículo científico publicado en 2010

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

artículo científico publicado en 2014

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process

artículo científico

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

artículo científico publicado en 2011

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis

artículo científico publicado en 2020

Dexpanthenol enemas in ulcerative colitis: a pilot study

artículo científico publicado en 1997

Diagnosis and management of pouchitis

artículo científico publicado en 2003

Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease

artículo científico publicado en 2008

Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health

artículo científico publicado en 2010

Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis

artículo científico publicado en 2019

Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials

artículo científico publicado en 2016

Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease

artículo científico publicado en 2020

Do not assume symptoms indicate failure of anti-tumor necrosis factor therapy in Crohn's disease

artículo científico publicado en 2011

Dosage adjustment during long-term adalimumab treatment for Crohnʼs disease: Clinical efficacy and pharmacoeconomics ⬇️

artículo científico publicado el 1 de enero de 2011

Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Restaurantmanhaj's

artículo científico publicado en 2014

Early Combined Immunosuppression May Be More Effective for Reducing Complications in Isolated Colonic- vs Ileal-Dominant Crohn Disease

artículo científico publicado en 2020

Early Crohn disease: a proposed definition for use in disease-modification trials

scientific article published on 01 February 2010

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

artículo científico publicado en 2015

Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT

scientific article published on 19 March 2019

Early combined immunosuppression reduces complications in long-standing Crohn's disease: a post hoc analysis of REACT

artículo científico publicado en 2020

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

artículo científico publicado en 2011

Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy

artículo científico publicado en 2004

Early remission status predicts long-term outcomes in patients with Crohn's disease treated with certolizumab pegol

artículo científico publicado en 2016

Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies

artículo científico publicado en 2011

Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change

artículo científico

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study

artículo científico publicado en 2017

Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease

artículo científico publicado en 2016

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis

artículo científico publicado en 2009

Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis

scientific article published on 01 May 2007

Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis

scientific article published on 01 January 2007

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

artículo científico publicado en 2017

Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease

artículo científico publicado en 2017

Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease

scientific article published on 04 July 2019

Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study

artículo científico publicado en 2008

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy

artículo científico publicado en 2016

Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed

artículo científico publicado en 2014

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis

scientific article published on 23 November 2018

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies

Efficacy and Safety of Continued Treatment with Mirikizumab in a Phase 2 Trial of Patients with Ulcerative Colitis

scientific article published on 17 September 2020

Efficacy and Safety of Endoscopic Balloon Dilatation of Ileoanal Pouch Strictures.

artículo científico publicado en 2018

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis

scientific article published on 09 November 2019

Efficacy and Safety of Extended Induction with Tofacitinib for the Treatment of Ulcerative Colitis

artículo científico publicado en 2020

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis

scientific article published on 04 September 2019

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease

artículo científico publicado en 2020

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis

scientific article published on 28 August 2019

Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease

scientific article published on 24 April 2020

Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

artículo científico publicado en 2019

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials

artículo científico publicado en 2008

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

artículo científico publicado en 2020

Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease

artículo científico publicado en 2018

Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis

scientific article published on 15 March 2011

Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.

artículo científico publicado en 2011

Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials

artículo científico publicado en 2015

Efficient Early Drug Development for Ulcerative Colitis

artículo científico publicado en 2016

Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study

artículo científico publicado en 2015

Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study

artículo científico

Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death

artículo científico publicado en 2018

Emerging Treatment Options in Mild to Moderate Ulcerative Colitis

artículo científico publicado en 2015

Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn's disease

artículo científico publicado en 2013

Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease

scientific article published on 01 May 2005

Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease

artículo científico publicado en 2013

Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease

artículo científico publicado en 2016

Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis

artículo científico publicado en 2015

Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy

artículo científico publicado en 2012

Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease

scientific article published on 04 July 2019

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease

artículo científico publicado en 2009

Epidemiology of inflammatory bowel disease

scientific article published on 01 March 2002

Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine

artículo científico publicado en 2002

Erratum: Corrigendum: The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Respo

article

Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine

artículo científico publicado en 2003

Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis.

artículo científico publicado en 2014

Estimates of the Prevalence and Effects of Food Insecurity and Social Support on Financial Toxicity in and Healthcare Use by Patients with Inflammatory Bowel Diseases

scientific article published on 08 June 2020

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

artículo científico publicado en 2014

Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program

artículo científico publicado en 2020

Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study

scientific article published on 27 September 2020

Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease

scientific article published on 15 April 2019

Evolving Concepts in Phases I and II Drug Development for Crohn's Disease

artículo científico publicado en 2016

Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary

scientific article published on 07 September 2018

Evolving definitions of remission in Crohn's disease

artículo científico publicado en 2013

Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials

artículo científico publicado en 2013

Exposure-Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis

artículo científico publicado en 2020

Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

artículo científico publicado en 2017

Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease

artículo científico publicado en 2017

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study

artículo científico publicado en 2009

Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease

artículo científico publicado en 2018

Factors associated with short- and long-term outcomes of therapy for Crohn's disease

artículo científico publicado en 2014

Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease

scientific article published on 01 May 2006

Feasibility of endoscopic assessment and treating to target to achieve mucosal healing in ulcerative colitis

artículo científico publicado en 2014

Fecal calprotectin-guided dosing of mesalamine in ulcerative colitis: concept proved but more data needed

artículo científico publicado en 2014

Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation

scientific article published on 01 June 2003

First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis

artículo científico publicado en 2020

Fistulas to the urinary system in Crohn's disease: clinical features and outcomes

artículo científico publicado en 2002

Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3.

artículo científico publicado en 2014

Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2020

Frailty is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases

scientific article published on 12 August 2020

Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity

artículo científico publicado en 2020

Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis

artículo científico publicado en 2018

Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease

artículo científico publicado en 2018

Global chemical effects of the microbiome include new bile-acid conjugations

artículo científico publicado en 2020

Head-to-head Comparative Studies: Challenges and Opportunities?

artículo científico publicado en 2017

Health-related quality of life during natalizumab maintenance therapy for Crohn's disease

artículo científico publicado en 2007

Henoch-schönlein purpura in an adult mimicking Crohn's disease and pyoderma gangrenosum

scientific article published on 01 July 2011

Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses

artículo científico publicado en 2020

Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review for Development of a Core Outcome Set.

artículo científico publicado en 2018

High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis

artículo científico publicado en 2018

Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

scientific article published on 01 May 2019

Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission

artículo científico publicado en 2020

Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices

artículo científico publicado en 2014

Histologic scoring indices for evaluation of disease activity in Crohn's disease.

artículo científico

Histologic scoring indices for evaluation of disease activity in Crohn’s disease

Histologic scoring indices for evaluation of disease activity in ulcerative colitis

artículo científico publicado en 2014

Host engulfment pathway controls inflammation in inflammatory bowel disease

scientific article published on 30 January 2020

How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease

artículo científico publicado en 2016

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

artículo científico publicado en 2006

IBD: Indication extrapolation for anti-TNF biosimilars

artículo científico publicado en 2015

IBD: Measuring what counts--endoscopic assessment in IBD.

artículo científico publicado en 2013

IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease

scientific article published on 01 January 2020

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

artículo científico

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease

article

Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency

artículo científico publicado en 2015

Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis

scientific article published on 01 August 2019

Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases

scientific article published on 01 April 2019

Impact of Obesity on Short- and Intermediate-Term Outcomes in Inflammatory Bowel Diseases: Pooled Analysis of Placebo Arms of Infliximab Clinical Trials

artículo científico publicado en 2018

Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease

artículo científico publicado en 2018

Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota

artículo científico publicado en 2006

Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials

scientific article published on 01 January 2019

Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis

artículo científico publicado en 2016

Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors

scientific article published on 07 May 2020

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data

artículo científico publicado en 2010

Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease

artículo científico publicado en 2013

Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis

artículo científico publicado en 2020

Indeterminate colitis: a review of the concept--what's in a name?

artículo científico publicado en 2008

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.

artículo científico publicado en 2015

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

artículo científico publicado en 2017

Infections and Cardiovascular Complications are Common Causes for Hospitalization in Older Patients with Inflammatory Bowel Diseases.

artículo científico publicado en 2018

Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship

artículo científico publicado en 2013

Inflammatory bowel disease in the setting of autoimmune pancreatitis

scientific article published on September 2009

Inflammatory bowel disease: clinical aspects and established and evolving therapies

artículo científico publicado en 2007

Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative Colitis

artículo científico publicado en 2018

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection

artículo científico publicado en 2016

Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience.

artículo científico publicado en 2018

Infliximab for Crohn's disease: the first 500 patients followed up through 2009.

artículo científico publicado en 2012

Infliximab for induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2005

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians

artículo científico publicado en 2002

Infliximab versus ciclosporin in severe ulcerative colitis.

artículo científico publicado en 2012

Infliximab, azathioprine, or combination therapy for Crohn's disease

article

Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?

artículo científico publicado en 2002

Innovations in Oral Therapies for Inflammatory Bowel Disease

scientific article published on 01 August 2019

Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease

artículo científico publicado en 2009

Internet use by patients in an inflammatory bowel disease specialty clinic

artículo científico publicado en 2007

Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases

artículo científico publicado en 2016

Introducing vedolizumab to clinical practice: who, when, and how?

artículo científico publicado en 2015

Is there still a role for thiopurines in Crohn's disease?

artículo científico publicado en 2013

Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2016

Letter: combination of biologics in inflammatory bowel diseases. Authors' reply

scientific article published on 01 August 2020

Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply

artículo científico publicado en 2020

Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply

scientific article published on 01 June 2020

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

artículo científico publicado en 2001

Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension

artículo científico publicado en 2018

Long-term Efficacy of Vedolizumab for Crohn's Disease

artículo científico publicado en 2016

Long-term Efficacy of Vedolizumab for Ulcerative Colitis

artículo científico publicado en 2016

Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts

artículo científico publicado en 2010

Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.

artículo científico publicado en 2018

Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota

artículo científico publicado en 2002

Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies

scientific article published on 11 April 2011

Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study

artículo científico

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials.

artículo científico publicado en 2019

Long-term safety of vedolizumab for inflammatory bowel disease

scientific article published on 02 September 2020

Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review

artículo científico publicado en 2011

Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression

artículo científico publicado en 2016

Lymphocytic colitis: clinical features, treatment, and outcomes

artículo científico publicado en 2002

MHC Class II alleles in ulcerative colitis-associated colorectal cancer

artículo científico

MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.

artículo científico publicado en 2008

MRI scoring indices for evaluation of disease activity and severity in Crohn’s disease

artículo científico publicado en 2015

Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation

artículo científico publicado en 2015

Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year

artículo científico publicado en 2016

Maintenance therapy with certolizumab pegol for Crohn's disease

artículo científico publicado en 2007

Management of Crohn's disease in adults

artículo científico publicado en 2001

Management of Crohn's disease in adults.

artículo científico publicado en 2009

Management of Crohn's disease of the ileoanal pouch with infliximab.

artículo científico publicado en 2003

Market Access Analysis of Biologics and Small-Molecule Inhibitors for Inflammatory Bowel Disease Among US Health Insurance Policies

scientific article published on 28 March 2019

Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity

artículo científico publicado en 2010

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

artículo científico publicado en 2001

Metagenomics-Based, Strain-Level Analysis of Escherichia coli From a Time-Series of Microbiome Samples From a Crohn's Disease Patient

artículo científico publicado en 2018

Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer

artículo científico publicado en 2010

Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians

artículo científico publicado en 2018

Microscopic colitis is not associated with cholecystectomy or appendectomy

artículo científico

Microscopic colitis: a review

artículo científico publicado en 2002

Mid pouch strictureplasty for Crohn's disease after ileal pouch-anal anastomosis: an alternative to pouch excision

artículo científico publicado en 2004

Modeling Endoscopic Improvement after Induction Treatment with Mesalamine in Patients with Mild-to-Moderate Ulcerative Colitis

scientific article published on 03 December 2020

Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 Study

scientific article published on 16 December 2019

Mycobacterium marinum infection in the setting of antitumor necrosis factor alpha therapy for Crohn's disease

artículo científico publicado en 2010

Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation

artículo científico publicado en 2011

N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis

artículo científico publicado en 2002

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

artículo científico publicado en 2005

Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial

artículo científico publicado en 2007

National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States

artículo científico publicado en 2020

Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

artículo científico publicado en 2017

New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?

artículo científico publicado en 2015

Next-Generation Therapeutics for Inflammatory Bowel Disease

artículo científico publicado en 2016

No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials

artículo científico publicado en 2018

No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy

artículo científico publicado en 2020

Non-cirrhotic portal hypertension due to 6-mercaptopurine use for Crohn's disease.

artículo científico publicado en 2014

Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease

artículo científico publicado en 2018

O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohnʼs Disease Refractory to Anti-TFNα

Obesity Is Independently Associated With Higher Annual Burden and Costs of Hospitalization in Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2018

Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials

scientific article published on 05 June 2018

Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.

artículo científico publicado en 2018

Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes

artículo científico publicado en 2016

Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials

artículo científico

Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis

artículo científico publicado en 2012

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

artículo científico publicado en 2013

Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study

artículo científico publicado en 2012

Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis

artículo científico publicado en 2010

Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis

artículo científico publicado en 2011

Once-daily, high-concentration MMX mesalamine in active ulcerative colitis

scientific article published on 12 October 2006

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2.

artículo científico publicado en 2012

Onercept for Moderate-to-Severe Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

article

Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab

artículo científico publicado en 2009

Optimizing sequencing protocols for leaderboard metagenomics by combining long and short reads

artículo científico publicado en 2019

Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy.

artículo científico publicado en 2011

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomized RIVETING Trial

scientific article published on 08 December 2020

Outcomes of computed tomography and magnetic resonance enterography in clinical practice of inflammatory bowel disease

artículo científico

Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study

artículo científico publicado en 2013

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

artículo científico publicado en 2016

Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study

scientific article published on 15 June 2020

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

artículo científico publicado en 2005

Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease

artículo científico publicado en 2014

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

artículo científico publicado en 2018

Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data

artículo científico publicado en 2018

Perianal Crohn's disease findings other than fistulas in a population-based cohort

artículo científico publicado en 2011

Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease

artículo científico publicado en 2010

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients with Crohn's Disease

artículo científico publicado en 2018

Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies

scientific article published on 20 July 2016

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study

artículo científico publicado en 2017

Photodynamic therapy as a new treatment modality for inflammatory and infectious conditions

artículo científico

Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.

artículo científico publicado en 2006

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease

artículo científico publicado en 2016

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease

artículo científico publicado en 2017

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2017

Placebo response and remission rates in randomized trials of induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2015

Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease

artículo científico publicado en 2004

Population Health Management for Inflammatory Bowel Disease

artículo científico publicado en 2017

Population Pharmacokinetics and Exposure-Response Modeling of Golimumab in Adults With Moderately to Severely Active Ulcerative Colitis

scientific article published on 22 January 2020

Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease

artículo científico publicado en 2015

Positioning Therapies in the Management of Crohn's Disease

scientific article published on 30 October 2019

Positioning biologic therapy for Crohn's disease and ulcerative colitis

artículo científico publicado en 2007

Positioning novel biologic, probiotic, and apheresis therapies for Crohn's disease and ulcerative colitis

artículo científico publicado en 2005

Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.

artículo científico publicado en 2018

Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.

artículo científico publicado en 1994

Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group

scientific article published on 16 January 2020

Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study

artículo científico publicado en 2006

Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease

artículo científico publicado en 2018

Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing

scientific article published on 09 August 2020

Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy

artículo científico publicado en 2010

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report

scientific article published on 19 July 2018

Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease

artículo científico publicado en 2020

Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California

artículo científico publicado en 2007

Prevalence of Fistulizing Crohn's Disease in the United States: Estimate From a Systematic Literature Review Attempt and Population-Based Database Analysis

scientific article published on 01 October 2019

Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis

scientific article published on 22 November 2019

Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography.

artículo científico publicado en 2008

Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis

artículo científico publicado en 2018

Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational study

artículo científico publicado en 2014

Progression of Elderly-Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-based Cohort Studies

artículo científico publicado en 2020

Project Sonar: A Community Practice-based Intensive Medical Home for Patients With Inflammatory Bowel Diseases

scientific article published on 24 August 2018

Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease

artículo científico publicado en 2009

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis

artículo científico publicado en 2010

Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease

artículo científico publicado en 2015

Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein

artículo científico publicado en 2006

Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis

artículo científico publicado en 2015

Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis

scientific article published on 24 May 2016

Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis

artículo científico publicado en 2015

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis

artículo científico publicado en 2015

Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab ⬇️

artículo científico publicado el 12 de enero de 2011

Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease

artículo científico publicado en 2013

Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

artículo científico publicado en 2015

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

artículo científico publicado en 2008

Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials

scientific article published on 01 September 2019

Rate of Risk Factors for and Interventions to Reduce Hospital Readmission in Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2019

Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease

artículo científico publicado en 2010

Refining the role of TNF antagonists for Crohn's disease. Introduction

artículo científico publicado en 2007

Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study

artículo científico publicado en 2016

Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study

artículo científico publicado en 2010

Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis

artículo científico publicado en 2020

Relationship of C-reactive protein with clinical response after therapy with ustekinumab in Crohn's disease

article

Relationships between C-reactive protein concentration and genotype in healthy volunteers

artículo científico publicado en 2009

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

artículo científico publicado en 2008

Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis

Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease

artículo científico publicado en 2015

Reliability and initial validation of the ulcerative colitis endoscopic index of severity

artículo científico publicado en 2013

Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease

scientific article published on 29 August 2019

Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance Enterography

artículo científico publicado en 2018

Reply

artículo científico publicado en 2016

Reply: To PMID 24036054.

artículo científico publicado en 2015

Reply: budesonide

artículo científico publicado en 2013

Reproducibility of histological assessments of disease activity in UC.

artículo científico publicado en 2014

Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis

scientific article published on 01 September 2007

Response to Placebo, Measured by Endoscopic Evaluation of Crohn's Disease Activity, in a Pooled Analysis of Data From 5 Randomized Controlled Induction Trials

artículo científico publicado en 2019

Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease

artículo científico publicado en 2017

Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial

scientific article published on 03 August 2018

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2018

Reversal of Multifocal Low- and High-Grade Dysplasia in Patients With an Ileoanal Pouch ⬇️

artículo científico publicado el 25 de enero de 2011

Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease

scientific article published on September 2008

Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study

scientific article published on 01 October 2007

Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study

artículo científico publicado en 2018

Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort

artículo científico publicado en 2010

Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota

artículo científico publicado en 2007

Risk factors for lymphoma in patients with inflammatory bowel disease: a case-control study.

artículo científico publicado en 2013

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

artículo científico publicado en 2008

Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease

artículo científico publicado en 2012

Risk of Relapse in Patients with Ulcerative Colitis with Persistent Endoscopic Healing: A Durable Treatment Endpoint

scientific article published on 10 September 2020

Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota

scientific article published on 01 November 2003

Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota

artículo científico publicado en 2006

Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse

artículo científico publicado en 2015

Role of interventional inflammatory bowel disease in the era of biological therapy: a position statement from the Global Interventional IBD Group

artículo científico publicado en 2018

Routine incorporation of the local read in Crohn's disease clinical trials? Not so fast

artículo científico publicado en 2021

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

artículo científico publicado en 2020

Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials

scientific article published on 23 November 2018

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

scientific article published on 23 September 2020

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

artículo científico publicado en 2002

Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines

artículo científico publicado en 2004

Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry

artículo científico publicado en 2012

Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

artículo científico publicado en 2006

Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease

artículo científico publicado en 2018

Setting a high threshold for noninferiority: mesalamine and budesonide in Crohn's disease

artículo científico publicado en 2011

Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index.

artículo científico publicado en 2011

Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis

scientific article published on 21 November 2019

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis

scientific article published on 06 January 2019

Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases?

artículo científico publicado en 2019

Similar Pharmacokinetics of Three Dosing Regimens Comprising Two Oral Delayed-Release Mesalamine Formulations in Healthy Adult Volunteers: Randomised, Open-Label, Parallel-Group Study

scientific article published on 15 July 2020

Similar outcomes of surgical and medical treatment of intra-abdominal abscesses in patients with Crohn's disease

artículo científico publicado en 2011

Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial.

artículo científico publicado en 2008

State of the art: IBD therapy and clinical trials in IBD.

artículo científico publicado en 2005

Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease

artículo científico publicado en 2013

Strategies for the care of adults hospitalized for active ulcerative colitis

artículo científico publicado en 2012

Studies in human intestinal tissues: is it time to reemphasize research in human immunology?

artículo científico publicado en 2014

Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis

artículo científico publicado en 2013

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis

artículo científico publicado en 2013

Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease

artículo científico publicado en 2012

Successful use of infliximab in the treatment of corticosteroid dependent collagenous colitis

artículo científico publicado en 2013

Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004)

artículo científico publicado en 2012

Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004.

artículo científico publicado en 2006

Symptomatic overlap between irritable bowel syndrome and microscopic colitis

scientific article published on 01 February 2007

Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a prospective study

artículo científico publicado en 2013

Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis

artículo científico publicado en 2016

Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis

artículo científico publicado en 2017

Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn's disease

artículo científico publicado en 2018

Systematic review and network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis

artículo científico publicado en 2017

Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases

scientific article published on 04 September 2019

Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis

artículo científico publicado en 2018

Systematic review with meta-analysis: recurrence of Crohn's disease after total colectomy with permanent ileostomy

artículo científico publicado en 2016

Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases

artículo científico publicado en 2020

Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.

artículo científico publicado en 2014

Systematic review: Safety of balloon assisted enteroscopy in Crohn's disease

artículo científico publicado en 2016

Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial

artículo científico publicado en 2003

Taking a closer look at IBD

artículo científico publicado en 2014

Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists

The Crohn's Disease-Ulcerative Colitis Clinical Appraisal

artículo científico publicado en 2016

The Crohn's Disease-Ulcerative Colitis Clinical Appraisal Update: Emerging Trends in Clinical Practice

artículo científico publicado en 2016

The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease

artículo científico publicado en 2018

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

artículo científico publicado en 2015

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics

artículo científico publicado en 2010

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

artículo científico publicado en 2010

The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety

artículo científico

The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane Reviews

artículo científico publicado en 2016

The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.

artículo científico publicado en 2016

The effectiveness of budesonide therapy for Crohn's disease

artículo científico publicado en 2002

The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.

artículo científico publicado en 2007

The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis

artículo científico publicado en 2010

The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain

artículo científico publicado en 2004

The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota

artículo científico publicado en 2006

The expanding therapeutic armamentarium for inflammatory bowel disease: how to choose the right drug(s) for our patients?

artículo científico publicado en 2017

The fate of low grade dysplasia in ulcerative colitis

artículo científico publicado en 2002

The natural history of adult Crohn's disease in population-based cohorts

artículo científico publicado en 2009

The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota

artículo científico publicado en 2002

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

artículo científico publicado en 2014

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis

artículo científico

The safety of vedolizumab for ulcerative colitis and Crohn's disease

artículo científico publicado en 2016

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

artículo científico publicado en 2004

Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease

artículo científico publicado en 2014

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice

artículo científico publicado en 2020

Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives

artículo científico

Therapeutic drug monitoring of biologics for inflammatory bowel disease

artículo científico publicado en 2011

Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel disease

artículo científico publicado en 2012

Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis

artículo científico publicado en 2020

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

artículo científico publicado en 2017

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.

artículo científico publicado en 2017

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

artículo científico publicado en 2017

Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.

artículo científico publicado en 2012

Toward a personalized medicine approach to the management of inflammatory bowel disease

artículo científico

Tracking Human Gut Microbiome Changes Resulting from a Colonoscopy

artículo científico publicado en 2017

Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease

artículo científico publicado en 2009

Treat to target: a proposed new paradigm for the management of Crohn's disease

artículo científico

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

artículo científico publicado en 2014

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis

artículo científico publicado en 2015

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis

artículo científico publicado en 2010

Treatment of Crohn's disease with certolizumab pegol

artículo científico publicado en 2007

Tumor necrosis factor-alpha antagonists twenty years later: what do Cochrane reviews tell us?

artículo científico publicado en 2014

Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.

artículo científico publicado en 2008

US Practice Patterns and Impact of Monitoring for Mucosal Inflammation After Biologic Initiation in Inflammatory Bowel Disease

artículo científico publicado en 2019

Ulcerative colitis

artículo científico publicado en 2012

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival

artículo científico publicado en 2000

Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease

artículo científico publicado en 2020

Update on Janus kinase antagonists in inflammatory bowel disease

artículo científico publicado en 2014

Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

artículo científico publicado en 2007

Use of azathioprine and 6MP in postoperative Crohn's: changing natural history or just along for the ride?

artículo científico publicado en 2009

Ustekinumab IV 6 mg/kg Loading Dose Re-induction Improves Clinical and Endoscopic Response in Crohn's disease: A Case Series.

artículo científico publicado en 2018

Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis: Ustekinumab PK and exposure-response in UC

artículo científico publicado en 2019

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

artículo científico publicado en 2016

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

artículo científico publicado en 2019

Ustekinumab induction and maintenance therapy in refractory Crohn's disease

artículo científico publicado en 2012

Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy

artículo científico publicado en 2020

Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis

artículo científico publicado en 2014

Validation of a lower radiation computed tomography enterography imaging protocol to detect Crohn's disease in the small bowel.

artículo científico publicado en 2011

Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

artículo científico publicado en 2013

Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease

artículo científico publicado en 2015

Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort

artículo científico publicado en 2015

Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures.

artículo científico publicado en 2012

Variation in severity assessment and initial mesalamine dose selection for ulcerative colitis in community practice

artículo científico publicado en 2006

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

artículo científico publicado en 2016

Vedolizumab as induction and maintenance therapy for Crohn's disease

artículo científico publicado en 2013

Vedolizumab as induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2013

Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

artículo científico publicado en 2018

Vedolizumab for the treatment of moderately to severely active ulcerative colitis.

artículo científico

Vedolizumab in Patients With Common Variable Immune Deficiency and Gut Inflammation

artículo científico publicado en 2017

Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme

scientific article published on 09 October 2019

Venous thromboembolism in inflammatory bowel disease

artículo científico publicado en 2004

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda